Moshe Talpaz

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 16

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Blood advances

American journal of hematology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

The University of Michigan - Michigan Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

The University of Michigan - Michigan Medicine Feb 01 2005

United States

Alexander J. Trotman Professor for Leukemia Research :: Department of Internal Medicine, Division of Hematology Oncology

The University of Texas MD Anderson Cancer Center Jan 01 2004 - Jan 31 2006

United States

Professor of Medicine :: Department of Experimental Therapeutics

The University of Texas MD Anderson Cancer Center Aug 01 1998 - Jan 31 2006

United States

David Bruton, Jr. Endowed Chair :: Department of Bioimmunotherapy

The University of Texas MD Anderson Cancer Center Feb 01 2000 - Dec 31 2003

United States

Chairman :: Department of Bioimmunotherapy

The University of Texas MD Anderson Cancer Center Sep 01 1992 - Dec 31 2000

United States

Professor of Medicine :: Department of Medical Oncology

The University of Texas MD Anderson Cancer Center Jul 01 1995 - Jan 31 2000

United States

Chairman ad interim :: Department of Bioimmunotherapy

The University of Texas MD Anderson Cancer Center Jan 01 1993 - Jun 30 1995

United States

Deputy Department Chairman, Clinical Affairs :: Department of Clinical Investigation, Division of Medicine

The University of Texas MD Anderson Cancer Center Aug 01 1986 - Sep 30 1992

United States

Associate Professor of Medicine :: Section of Biologic Therapy in Hematologic Malignancies

The University of Texas MD Anderson Cancer Center Jan 01 1990 - Aug 31 1992

United States

Deputy Chairman :: Department of Clinical Immunology and Biological Therapy

MD Anderson Cancer Center Aug 01 1981 - Jul 31 1986

United States

Assistant Professor :: Department of Clinical Immunology and Biological Therapy

University of Texas MD Anderson Cancer Center Aug 01 1981 - Jul 31 1982

United States

Clinical Instructor :: Department of Clinical Immunology and Biological Therapy

The University of Texas MD Anderson Cancer Center Aug 01 1979 - Jul 30 1980

United States

Postdoctoral Fellow in Immunology :: Department of Developmental Therapeutics

Soroka Medical Center Aug 02 1978 - Jul 30 1979

Israel

Attending Physician :: Department of Medicine

Israel Defense Forces Jan 01 1973 - Jul 30 1974

Israel

Medical Officer

Publications

Malathi Kandarpa, Dan R Robinson, Yi-Mi Wu, Tingting Qin, Kristen Pettit, Qing Li, Gary D Luker, Maureen A Sartor, Arul M Chinnaiyan, Moshe Talpaz
Broad Next-Generation Integrated Sequencing of Myelofibrosis Identifies Disease-Specific and Age-Related Genomic Alterations. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Malathi Kandarpa, Dan R Robinson, Yi-Mi Wu, Tingting Qin, Kristen Pettit, Qing Li, Gary D Luker, Maureen A Sartor, Arul M Chinnaiyan, Moshe Talpaz
Broad Next-Generation Integrated Sequencing of Myelofibrosis Identifies Disease-Specific and Age-Related Genomic Alterations. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Malathi Kandarpa, Dan R Robinson, Yi-Mi Wu, Tingting Qin, Kristen Pettit, Qing Li, Gary D Luker, Maureen A Sartor, Arul M Chinnaiyan, Moshe Talpaz
Broad next generation integrated sequencing of myelofibrosis identifies disease-specific and age-related genomic alterations. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Amanpreet Kaur, Arunkumar Venkatesan, Malathi Kandarpa, Moshe Talpaz, Malini Raghavan
Lysosomal degradation targets mutant calreticulin and the thrombopoietin receptor in myeloproliferative neoplasms. Blood advances 8 (13) (2024)
Amanpreet Kaur, Arunkumar Venkatesan, Malathi Kandarpa, Moshe Talpaz, Malini Raghavan
Lysosomal degradation targets mutant calreticulin and the thrombopoietin receptor in myeloproliferative neoplasms. Blood advances 8 (13) (2024)
Amanpreet Kaur, Arunkumar Venkatesan, Malathi Kandarpa, Moshe Talpaz, Malini Raghavan
Lysosomal degradation targets mutant calreticulin and the thrombopoietin receptor in myeloproliferative neoplasms. Blood advances 8 (13) (2024)
Malathi Kandarpa, Dan R Robinson, Yi-Mi Wu, Tingting Qin, Kristen Pettit, Qing Li, Gary D Luker, Maureen A Sartor, Arul M Chinnaiyan, Moshe Talpaz
Broad Next-Generation Integrated Sequencing of Myelofibrosis Identifies Disease-Specific and Age-Related Genomic Alterations. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
John O Mascarenhas, Marina Kremyanskaya, Andrea Patriarca, Francesca Palandri, Timothy Devos, Francesco Passamonti, Raajit K Rampal, Adam J Mead, Gabriella Hobbs, Joseph M Scandura, Moshe Talpaz, Nikki Granacher, Tim C P Somervaille, Ronald Hoffman, Marielle J Wondergem, Mohamed E Salama, Gozde Colak, Jike Cui, Jean-Jacques Kiladjian, Alessandro Maria Maria Vannucchi, Srdan Verstovsek, Natalia Curto-García, Claire N Harrison, Vikas K Gupta
MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
John O Mascarenhas, Anna Rita Migliaccio, Heidi E Kosiorek, Rupali Bhave, Jeanne M Palmer, Andrew T Kuykendall, Ruben A Mesa, Raajit K Rampal, Aaron T Gerds, Abdulraheem Yacoub, Kristen Pettit, Moshe Talpaz, Rami S Komrokji, Marina Kremyanskaya, Agapito Gonzalez, Frank Fabris, Kathryn Johnson, Mikaela Dougherty, Erin M McGovern, Juan Esteban Arango Ossa, Dylan Domenico, Noushin Farnoud, Rona Singer Weinberg, Amy Kong, Vesna Najfeld, Alessandro Maria Maria Vannucchi, Francesca Arciprete, Maria Zingariello, Mario Falchi, Mohamed E Salama, Carolyn Mead-Harvey, Amylou C Dueck, Lilian Varricchio, Ronald Hoffman
A Phase 1b trial of AVID200, a TGFβ 1/3 trap, in patients with myelofibrosis. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Ellin Berman, Neil P Shah, Michael W Deininger, Jessica K Altman, Maria Amaya, Kebede H Begna, Ravi Bhatia, Onyee Chan, Robert H Collins, Peter Curtin, Daniel J DeAngelo, Michael W Drazer, Lori Maness, Leland L Metheny, Sanjay Mohan, Joseph Moore, Vivian Oehler, Keith W Pratz, Iskra Pusic, Michal Rose, William Shomali, B Douglas Smith, Michael Styler, Kendra Sweet, Moshe Talpaz, Tiffany Tanaka, Srinivas Tantravahi, Steven Tsai, Jennifer Vaughn, Jeanna Welborn, David Yang, Michael Mauro, Jorge E Cortes, Jerald Radich, Brian J Druker
CML and the WHO: Why? Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Hagop M Kantarjian, Elias J Jabbour, Michael Deininger, Elisabetta Abruzzese, Jane Apperley, Jorge E Cortes, Charles Chuah, Daniel J DeAngelo, John DiPersio, Andreas Hochhaus, Jeffrey Lipton, Franck E Nicolini, Javier Pinilla-Ibarz, Delphine Rea, Gianantonio Rosti, Philippe Rousselot, Neil P Shah, Moshe Talpaz, Shouryadeep Srivastava, Xiaowei Ren, Michael Mauro
Ponatinib after failure of second-generation tyrosine kinase inhibitor in resistant chronic-phase chronic myeloid leukemia. American journal of hematology 97 (11) (2022)
Claire N Harrison, Vikas K Gupta, Aaron T Gerds, Raajit K Rampal, Srdan Verstovsek, Moshe Talpaz, Jean-Jacques Kiladjian, Ruben A Mesa, Andrew T Kuykendall, Alessandro Maria Maria Vannucchi, Francesca Palandri, Sebastian Grosicki, Timothy Devos, Eric Jourdan, Marielle J Wondergem, Haifa Kathrin Al-Ali, Veronika Buxhofer-Ausch, Alberto Álvarez-Larrán, Andrea Patriarca, Marina Kremyanskaya, Adam J Mead, Sanjay Akhani, Yuri Sheikine, Gozde Colak, John O Mascarenhas
Phase III MANIFEST-2: pelabresib + ruxolitinib vs placebo + ruxolitinib in JAK inhibitor treatment-naive myelofibrosis. Future oncology (London, England) 18 (27) (2022)
Moshe Talpaz, Jean-Jacques Kiladjian
Fedratinib, a newly approved treatment for patients with myeloproliferative neoplasm-associated myelofibrosis. Leukemia 35 (1) (2020)
Moshe Talpaz, Giuseppe Saglio, Ehab Atallah, Philippe Rousselot
Dasatinib dose management for the treatment of chronic myeloid leukemia. Cancer 124 (8) (2018)
Jordan K Schaefer, Sarah M Choi, Gary D Luker, Thomas L Chenevert, Brian D Ross, Moshe Talpaz
Primary myelofibrosis evolving to an aplastic appearing marrow. Clinical case reports 6 (7) (2018)
Malathi Kandarpa, Yi-Mi Wu, Dan Robinson, Patrick William Burke, Arul M Chinnaiyan, Moshe Talpaz
Clinical characteristics and whole exome/transcriptome sequencing of coexisting chronic myeloid leukemia and myelofibrosis. American journal of hematology 92 (6) (2017)

Moshe Talpaz.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Moshe Talpaz